The Landmark Investment in Dental Artificial Intelligence Enables Pearl to Further Expand its Dental AI Solutions and Meaningfully Improve Oral Health Outcomes for Patients

对牙科人工智能的里程碑式投资使Pearl能够进一步扩展其牙科AI解决方案，并有意义地改善患者的口腔健康状况

Pearl, the global leader in dental AI, today announced that it has raised $58 million in Series B funding to accelerate its mission to elevate patient care in dentistry. Left Lane Capital led the round, with participation from Smash Capital, Alpha Partners, and existing investors, Craft Ventures and Neotribe Ventures.

牙科人工智能领域的全球领导者Pearl今天宣布，它已经在B系列资金中筹集了5800万美元，以加速其提高牙科患者护理水平的使命。Left Lane Capital领跑了这一轮，来自Smash Capital、Alpha Partners以及现有投资者、Craft Ventures和Neotribe Ventures的参与。

This funding marks the largest investment ever in dental artificial intelligence..

这笔资金是牙科人工智能领域有史以来最大的投资。。

With this investment, Pearl will continue to advance innovation in technologies that enhance the health of dental patients around the world by expanding its line of dental AI products, broadening its regulatory and patent portfolio, and increasing global access to the transformative benefits of AI in dentistry.

通过这项投资，Pearl将继续推进技术创新，通过扩大其牙科人工智能产品系列，扩大其监管和专利组合，以及增加全球获得人工智能在牙科领域的变革性益处，从而提高全球牙科患者的健康水平。

At present, Pearl’s machine learning and computer vision tools solve a core challenge in dentistry: inconsistency in diagnostic accuracy, which directly impacts the quality of patient care. The company’s AI serves as a real-time aid to help dentists read patient x-rays, deliver consistent, objective, and accurate diagnoses, and clearly communicate findings to patients with precision, clarity, and confidence..

目前，Pearl的机器学习和计算机视觉工具解决了牙科的一个核心挑战：诊断准确性不一致，这直接影响了患者护理的质量。该公司的人工智能可作为实时帮助，帮助牙医阅读患者的x光片，提供一致，客观和准确的诊断，并以精确，清晰和自信的方式将结果清楚地传达给患者。。

Since receiving the first-ever FDA clearance for AI software to help dental professionals detect multiple different pathologies and other conditions in x-rays, Pearl’s clinical AI has gained regulatory authorizations for chairside use in over 120 countries and recognition among TIME’s Best Inventions.

自从获得FDA首次批准AI软件帮助牙科专业人员检测x射线中的多种不同病理和其他疾病以来，Pearl的临床AI已在120多个国家获得椅旁使用的监管授权，并被《时代》杂志评为最佳发明。

The company plans to use the funding announced today both to accelerate the ongoing development of computer vision capabilities – including detection and tracking of disease in 3D and other imaging modalities – and introduce new AI tools to improve patient treatment planning, insurance claim approvals, and dental education..

该公司计划利用今天宣布的资金，加速计算机视觉能力的持续发展，包括3D和其他成像方式的疾病检测和跟踪，并引入新的人工智能工具来改进患者治疗计划、保险索赔批准和牙科教育。。

“In the field of healthcare, dentistry has become an AI standard-bearer, demonstrating the technology’s enormous utility and benefit in day-to-day patient care––and Pearl has led the AI charge in dentistry,” said Ophir Tanz, Founder and CEO at Pearl. “This historic funding round underscores the impact of Pearl’s capabilities and supports our belief that high-quality, AI-powered dental care should be accessible to everyone.

Pearl的创始人兼首席执行官Ophir Tanz表示：“在医疗保健领域，牙科已经成为人工智能的旗手，证明了该技术在日常患者护理中的巨大实用性和益处，Pearl在牙科领域领导了人工智能的发展。”。“这一历史性的融资回合强调了Pearl能力的影响，并支持我们的信念，即每个人都应该获得高质量的人工智能牙科护理。

With this investment, Pearl will continue to push the envelope, providing pioneering machine learning to improve oral health outcomes and strengthen trust between the patient and dental professionals.”.

通过这项投资，Pearl将继续努力，提供开创性的机器学习，以改善口腔健康状况，并加强患者与牙科专业人员之间的信任。”。

This investment follows a period of significant growth for Pearl. The company grew its revenue by 458% in 2023 and remains the only dental AI company with a global market presence. Pearl’s technology is used in dental practices across six continents and is commercially available to over 500,000 dental practices and millions of dental professionals worldwide.

这项投资是在珍珠公司经历了一段显著增长时期之后进行的。。Pearl的技术已在六大洲的牙科诊所中使用，全球有超过500000名牙科诊所和数百万牙科专业人员可在市场上买到。

The company has also integrated its AI into dozens of popular imaging and practice management systems and is the preferred radiologic AI provider for leading dental technology distributors..

该公司还将其人工智能集成到数十种流行的成像和实践管理系统中，是领先牙科技术分销商首选的放射人工智能供应商。。

“We have spent the past year evaluating this market and it is clear that Pearl stands above peers at the forefront of dental innovation,” said Vinny Pujji, Managing Partner at Left Lane Capital. “Pearl’s pioneering dental Al improves diagnostic accuracy and efficiency while transforming the provider-patient relationship.

Left Lane Capital管理合伙人维尼·普吉（VinnyPujji）表示：“过去一年，我们一直在评估这一市场，很明显，珀尔在牙科创新领域处于领先地位。”。“Pearl开创性的牙科Al提高了诊断的准确性和效率，同时改变了医患关系。

We’re confident in Pearl’s ability to continue setting new standards of care and are thrilled to support their next phase of growth.”.

我们相信Pearl有能力继续制定新的护理标准，并很高兴能够支持他们下一阶段的发展。”。

Pearl’s AI technology offers a seamless and less invasive approach to dental diagnostics. By accurately detecting disease and displaying clinical findings that are easy for patients to understand, the company’s FDA-cleared software enhances the efficiency, consistency, and precision of radiologic exams, while also facilitating patient education and engagement in their dental health.

Pearl的人工智能技术为牙科诊断提供了一种无缝且侵入性较小的方法。通过准确检测疾病并显示患者易于理解的临床发现，该公司经FDA批准的软件提高了放射学检查的效率，一致性和准确性，同时也促进了患者的教育和参与他们的牙齿健康。

Leveraging its new funding, Pearl will enable dental professionals to continually raise the standard of care with more transparent, accurate, and objective diagnoses, more effective individualized care, and deeper patient trust in dentistry..

利用其新资金，Pearl将使牙科专业人员能够通过更透明，准确和客观的诊断，更有效的个性化护理以及更深入的患者对牙科的信任来不断提高护理标准。。

For more information on how Pearl’s suite of solutions can enhance your dental practice, visit hellopearl.com.

有关Pearl系列解决方案如何增强您的牙科实践的更多信息，请访问hellopearl.com。

‍About Pearl

‍关于Pearl

Pearl is an AI-driven company committed to enhancing patient care in dentistry. Founded in 2019 by a team with decades of experience developing successful, enterprise-grade computer vision solutions, Pearl introduced the first-ever FDA-cleared AI capable of reading and instantly identifying diseases in dental x-rays.

Pearl是一家人工智能驱动的公司，致力于加强牙科患者护理。Pearl于2019年由一个拥有数十年成功开发企业级计算机视觉解决方案经验的团队创建，推出了有史以来第一款FDA批准的人工智能，能够读取并立即识别牙科x射线中的疾病。

With regulatory clearance in 120 countries, Pearl’s AI assists dentists in making precise clinical decisions and effectively communicating with patients, thereby transforming the dental care experience worldwide. As dentistry’s global AI leader, Pearl is committed to the ongoing innovation of robust, accessible AI tools that improve patient health outcomes and build greater trust in dental medicine. To request a demo, please visit hellopearl.com/getdemo..

通过120个国家的监管许可，Pearl's AI帮助牙医做出精确的临床决策，并与患者进行有效沟通，从而改变全球牙科护理经验。作为牙科领域的全球人工智能领导者，Pearl致力于不断创新强大、易用的人工智能工具，以改善患者的健康状况，并建立对牙科医学的更大信任。要请求演示，请访问hellopearl.com/getdemo。。

About Left Lane Capital

关于Left Lane Capital

Founded in 2019, Left Lane Capital is a New York and London-based global venture capital and growth equity firm investing in internet and technology companies with a consumer orientation. Left Lane’s mission is to partner with extraordinary entrepreneurs who create category-defining companies across growth sectors of the economy, including software, healthcare, e-commerce, consumer, fintech, medtech, and other industries.

Left Lane Capital成立于2019年，是一家总部位于纽约和伦敦的全球风险投资和成长股权公司，以消费者为导向投资互联网和技术公司。Left Lane的使命是与杰出的企业家合作，他们在经济增长领域创建类别定义公司，包括软件、医疗保健、电子商务、消费者、金融科技、医疗科技和其他行业。

Select investments include Bilt Rewards, Polycam, Kings League, M1 Finance, Wayflyer, Masterworks, Blank Street, Talkiatry, LemFi, and more. For more information, please visit leftlane.com..

精选投资包括Bilt Rewards、Polycam、Kings League、M1 Finance、Wayflyer、Masterworks、Blank Street、Talkiatry、LemFi等。有关更多信息，请访问leftlane.com。。

Originally announced July 24th, 2024

最初于2024年7月24日宣布

TagsAlpha Partners Craft Ventures Health IT Funding Health IT Fundings Health IT Investment Left Lane Capital Neotribe Ventures Ophir Tanz Pearl Smash Capital Vinny Pujji

TagsAlpha Partners Craft Ventures Health IT Funding Health IT Fundings Health IT Investment Left Lane Capital Neotubree Ventures Ophir Tanz Pearl Smash Capital Vinny Pujji塔格萨尔法合作伙伴手工艺风险投资健康IT资金

Get Fresh Healthcare & IT Stories Delivered Daily

每天提供新鲜的医疗保健和IT故事

Join thousands of your healthcare & HealthIT peers who subscribe to our daily newsletter.

加入成千上万订阅我们每日新闻稿的healthcare&HealthIT同行。

We respect your privacy and will never sell or give out your contact information

我们尊重您的隐私，绝不出售或泄露您的联系信息